Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

Delhi HC Orders Arbitration in Medikabazaar Board Dispute, Tiwari Challenges Termination

No violation of Abbott's trademark: Delhi HC upholds trademark of Mebufen against Brufen

Farhat Nasim26 Oct 2024 5:18 PM IST

New Delhi: The Delhi High Court has upheld the Registrar of Trademarks' decision to reject an objection by pharmaceutical giant Abbott, which...

Medtronic gets USFDA nod for OmniaSecure defibrillation lead for placement within right ventricle

Philips, Medtronic Ink Advocacy Partnership to Enhance Stroke Care Access

Farhat Nasim26 Oct 2024 4:27 PM IST

Netherlands: Royal Philips, a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies,...

Biocon Told to Submit Detailed Toxicity, SAE Data on Semaglutide Prefilled Pen After Animal Deaths

Biocon Foundation Wins 2024 Doing Good for Bharat Award in Healthcare for eLAJ Smart Clinics

MD Bureau26 Oct 2024 2:38 PM IST

Bengaluru: Biocon Foundation, the CSR arm of the Biocon Group of Companies, announced that it has received the esteemed ‘Doing Good for Bharat...

Rhythm Pharma, Axovia Therapeutics Launch Joint Research Collaboration for Bardet-Biedl Syndrome

MD Bureau26 Oct 2024 11:00 AM IST

BOSTON: Rhythm Pharmaceuticals, Inc. and Axovia Therapeutics Ltd. have announced a collaborative research effort aimed at advancing insights into...

Merck, Eisai to shut down late stage trial of liver cancer therapy

Merck's KEYTRUDA Gains European Approval for Two New Gynecologic Cancer Treatments

MD Bureau25 Oct 2024 5:47 PM IST

With these approvals, KEYTRUDA is now authorized for 30 indications in the EU, including five in gynecologic cancers, Merck said in a statement.

Bayer, Dewpoint ink USD 424 million deal to develop breakthrough therapy for genetic heart disease

MD Bureau25 Oct 2024 3:34 PM IST

Berlin: Bayer has signed an exclusive licensing agreement with Dewpoint Therapeutics, Inc. for a heart disease program targeting patients with...

AMC Flags Human Trial Violations, Refers Case to Gujarat FDCA

Marinus Pharma Halts Development After Seizure Drug Fails Trial

MD Bureau25 Oct 2024 3:13 PM IST

Marinus said it will discontinue development of the drug, ganaxolone, and take further steps to reduce costs, including job cuts.

Strides Pharma Science Singapore arm, Kenox Pharma partner to develop multiple nasal spray products for US

Strides Pharma Posts Record Q2 Growth with Rs 12,011 Million Revenue, Highest Ever US Sales

MD Bureau25 Oct 2024 3:03 PM IST

Bengaluru: Strides Pharma Science Ltd. reported robust Q2FY25 financial results, ending September 30, 2024, with consolidated revenues at Rs 12,011...

'Insulin Tablets' banned, License of pharma firm cancelled after activist flags mislabeling risks for diabetics

Farhat Nasim25 Oct 2024 1:31 PM IST

New Delhi: The license of Bhargava Phytolabs, a Rajasthan-based pharmaceutical company, has been cancelled for manufacturing "Insulin Tablets," a...

Only D.Pharm, B.Pharm, M.Pharm, Pharm.D Holders Can Be Drug Wholesalers: DTAB

Farhat Nasim24 Oct 2024 6:02 PM IST

New Delhi: The Drugs Technical Advisory Board (DTAB) has reaffirmed its recommendation to finalize amendment to Rule 64 of the Drugs Rules, 1945,...

Even Healthcare raises Rs 252 crore in Series A funding to launch hospital operations, enhance patient care

MD Bureau24 Oct 2024 5:32 PM IST

Bengaluru: Even Healthcare, a Bengaluru-based managed care provider, recently secured USD 30 million (approximately Rs 252 crore) in a Series A...

Piramal Pharma arm, BrePco Biopharma get UKMHRA approval for Neoatricon in UK

Piramal Pharma Reports Over Fourfold Surge in Q2 Net Profit to Rs 23 Crore, Announces Expansion Plans

MD Bureau24 Oct 2024 4:35 PM IST

Revenue from operations rose to Rs 2,242 crore in the second quarter as compared with Rs 1,911 crore in the year-ago period, Piramal Pharma said.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok